LAVA Therapeutics (LVTX)
(Delayed Data from NSDQ)
$1.49 USD
+0.02 (1.02%)
Updated Sep 19, 2025 03:59 PM ET
After-Market: $1.49 +0.01 (0.34%) 7:58 PM ET
3-Hold of 5 3
D Value F Growth A Momentum F VGM
Fundamental Charts
About Market Cap
As of the previous market close, LAVA Therapeutics N.V. has a market cap of $38.67M, which represents its share price of $1.47 multiplied by its outstanding shares number of 26.31M. As a small-cap company, LVTX's shareholders are generally exposed to more risk than shareholders of mid and large-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
LVTX 1.49 +0.02(1.02%)
Will LVTX be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for LVTX based on the 1-3 month trading system that more than doubles the S&P 500.
Other News for LVTX
Hammer Candlestick appears for LVTX after 1.02% move
LVTX forms 20 Day Moving Average Resistance on September 18
Major Shareholder Sells Millions in LAVA Therapeutics Stock!
50 Day Moving Average Support appears for LVTX after 0.66% move
Is LVTX setting up for a drop? 20 Day Moving Average Resistance shows up after sliding 1.95%